259 related articles for article (PubMed ID: 31707011)
21. The Predictive Value of Pretreatment Lactate Dehydrogenase and Derived Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors: A Meta-Analysis.
Zhang Q; Gong X; Sun L; Miao L; Zhou Y
Front Oncol; 2022; 12():791496. PubMed ID: 35924149
[TBL] [Abstract][Full Text] [Related]
22. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses.
Mjaess G; Chebel R; Karam A; Moussa I; Pretot D; Abi Tayeh G; Sarkis J; Semaan A; Peltier A; Aoun F; Albisinni S; Roumeguère T
Acta Oncol; 2021 Jun; 60(6):704-713. PubMed ID: 33586577
[TBL] [Abstract][Full Text] [Related]
24. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.
Zhou L; Cai X; Liu Q; Jian ZY; Li H; Wang KJ
Sci Rep; 2015 Aug; 5():12733. PubMed ID: 26235332
[TBL] [Abstract][Full Text] [Related]
26. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.
Li J; Cheng Y; Ji Z
Medicine (Baltimore); 2019 Jan; 98(2):e14091. PubMed ID: 30633220
[TBL] [Abstract][Full Text] [Related]
28. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
Kim SI; Kim SJ; Kim SJ; Cho DS
Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of NLR in urinary cancers: a meta-analysis.
Wei Y; Jiang YZ; Qian WH
PLoS One; 2014; 9(3):e92079. PubMed ID: 24642859
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
Ethier JL; Desautels D; Templeton A; Shah PS; Amir E
Breast Cancer Res; 2017 Jan; 19(1):2. PubMed ID: 28057046
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Role of Pretreatment C-Reactive Protein to Albumin Ratio in Urological Cancers: A Systematic Review and Meta-Analysis.
Wu M; Zhou Y; Chen Q; Yu Z; Gu H; Lin P; Li Y; Liu C
Front Oncol; 2022; 12():879803. PubMed ID: 35480099
[TBL] [Abstract][Full Text] [Related]
32. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis.
Li M; Deng Q; Zhang L; He S; Rong J; Zheng F
Pathol Res Pract; 2019 Jan; 215(1):5-11. PubMed ID: 30401580
[TBL] [Abstract][Full Text] [Related]
33. Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy.
Templeton AJ; Rodríguez-Lescure Á; Ruíz A; Alba E; Calvo L; Ruíz-Borrego M; Santaballa A; Rodríguez CA; Crespo C; Ramos M; Gracia-Marco JM; Lluch A; Álvarez I; Casas MI; Sánchez-Aragó M; Caballero R; Carrasco E; Amir E; Martin M; Ocaña A;
Clin Transl Oncol; 2018 Dec; 20(12):1548-1556. PubMed ID: 29766456
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis.
Cao J; Zhu X; Zhao X; Li XF; Xu R
PLoS One; 2016; 11(7):e0158770. PubMed ID: 27368058
[TBL] [Abstract][Full Text] [Related]
36. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in patients with laryngeal cancer: a systematic review and meta-analysis.
Yang F; Huang Q; Guan Z; Diao Q
Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):417-425. PubMed ID: 32886184
[TBL] [Abstract][Full Text] [Related]
38. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
[TBL] [Abstract][Full Text] [Related]
39. The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.
Min GT; Li YM; Yao N; Wang J; Wang HP; Chen W
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29112283
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.
Bowen RC; Little NAB; Harmer JR; Ma J; Mirabelli LG; Roller KD; Breivik AM; Signor E; Miller AB; Khong HT
Oncotarget; 2017 May; 8(19):32171-32189. PubMed ID: 28418870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]